FDA Media Alert Detail

Drug Recall

FDA Drug Recall: Clindamycin Injection USP in 5% Dextrose, 900 mg/50 mL (18 mg/mL), in GALAXY 50 mL Single Dose Conta...

  • U.S. Food and Drug Administration
  • September 9, 2026
  • ID: D-0818-2026

Drug Enforcement Report Details

Recall NumberD-0818-2026
Recalling FirmBaxter Healthcare Corporation
ClassificationClass II
Voluntary / MandatedVoluntary: Firm initiated
Distribution PatternUS Nationwide; Puerto Rico; and Chile.
StatusOngoing
Product Description

Clindamycin Injection USP in 5% Dextrose, 900 mg/50 mL (18 mg/mL), in GALAXY 50 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Manufactured by: Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 43066-995-24.

Reason for Recall

CGMP Deviations

Code Information

Lot # NC194068, Exp Date: 10/29/2027.


Content syndicated from the U.S. Food and Drug Administration (FDA) drug enforcement reports database.